India - Medtech Opportunity Assessment Report 2014 is a comprehensive assessment of current and future surgical procedure volumes, healthcare and economic trends, and market opportunities in this region. This in-depth report is an essential resource for current and hopeful competitors selling medical products in India. The study quantifies, analyzes, and forecasts the Indian medical devices market. Historical data is for 2010-2012, most recent actual year data is for 2013, and forecasts exte...
China - Medtech Opportunity Assessment Report 2014 is a comprehensive assessment of current and future surgical procedure volumes, healthcare and economic trends, and market opportunities in this region. This in-depth report is an essential resource for current and hopeful competitors selling medical products in China. The study quantifies, analyzes, and forecasts the Chinese medical devices market. Historical data is for 2010-2012, most recent actual year data is for 2013, and forecasts exte...
United Kingdom - Medtech Opportunity Assessment Report 2014 is a comprehensive assessment of current and future surgical procedure volumes, healthcare and economic trends, and market opportunities in this region. This in-depth report is an essential resource for current and hopeful competitors selling medical products in the United Kingdom. The study quantifies, analyzes, and forecasts the UK medical devices market. Historical data is for 2010-2012, most recent actual year data is for 2013,...
Life Science Intelligence announces the availability of a detailed new report, United States Medtech Opportunity Assessment (MOA) 2014, detailing the country's demographic, economic, healthcare industry and device market opportunities and challenges, and forecasting nearly 200 surgical procedure volumes across 12 key medical specialty areas, through 2017. This valuable resource, containing more than 450 pages of timely, current data and analysis, provides your company with the key information ne...
Japan - Medtech Opportunity Assessment Report 2014 is a comprehensive assessment of current and future surgical procedure volumes, healthcare and economic trends, and market opportunities in this region. This in-depth report is an essential resource for current and hopeful competitors selling medical products in Japan. The study quantifies, analyzes, and forecasts the Japanese medical devices market. Historical data is for 2010-2012, most recent actual year data is for 2013, and forecasts extend...
Infant warmers, incubators, and hybrid systems generated $486 million in global revenues during 2013. The market for these devices, which is analyzed in LSI's new report, will continue to be shaped by regional and local trends in annual births and the delivery of neonatal care. As such, it will differ strikingly between developed and emerging markets, especially in countries where many births continue to take place outside of healthcare institutions; furthermore, limited purchasing resources as...
Global revenues from infant ventilators, jaundice management products, and neonatal and perinatal monitoring technologies reached $706 million in 2013. Explored in LSI's report, the market for these technologies will develop as a result of the global forces that are affecting the status of neonatal care, which include powerful regional and demographic trends; the transformation of institutional healthcare in emerging markets; trends in information technology and connectivity; and marketing and m...
Ventilators and airway management products generated $4.8 billion in global revenues during 2013. As discussed extensively in LSI\'s new report, the global market for these products will be affected by key regional differences. In the U.S., where respiratory caseloads are expected to rise, greater preference will be given to systems that enable use for patients at all levels of acuity as well as those that facilitate the transition from costly intensive care settings. The European market will be...
A timely and unique growth opportunity exists for cardiovascular device manufacturers seeking to offset some of the tepid or declining growth they have been experiencing in the US and Western European markets. As a result, multinational cardiovascular device companies have been increasing their investments in emerging nations - and they are reaping the rewards, with demand for some cardiovascular devices increasing at solid double-digit rates in many emerging countries, including the BRIC nation...
The global market for products used in surgical ophthalmology-which includes diagnostic devices, surgical systems (e.g., lasers and phacoemulsification machines), intraocular lens (IOL) implants and disposables, accessories, and aftermarket revenues from services and parts-was valued at $7.4 billion in 2012. Growth is expected through 2017, when the market reaches $9 billion, due to continued penetration of the population with cataracts (especially in emerging markets) as a result of efforts amo...
The global market for specialty surgical wound care products-which include sealants, glues, absorbable hemostats, and adhesion prevention products-was valued at $3.1 billion in 2012. Growth is being largely driven by the markets of Asia-Pacific and the Rest-of-the-World, where greater product availability, new indications, and underlying market dynamics-such as rising surgical procedure volumes-are helping to offset sluggishness in the U.S. market. While global revenues are expected to reach $4....
This report includes details on 27 emerging medical technology companies that have been identified by LSI\'s in-house research team in January 2013.
All companies include technology, market(s), key executive, and contact information.
Coverage includes innovations in a broad spectrum of medical technology areas including:
- Aesthetics/Dermatology Companies
- Biomaterials Companies
- Biotechnology/Cell Therapy Companies
- Cardiovascular Companies
- Dental Companies
- Diagnostics Compan...
This report includes details on 29 emerging medical technology companies that have been identified by LSI\'s in-house research team in February 2013.
All companies include technology, market(s), key executive, and contact information.
Coverage includes innovations in a broad spectrum of medical technology areas including:
- Aesthetics/Dermatology Companies
- Biomaterials Companies
- Biotechnology/Cell Therapy Companies
- Cardiovascular Companies
- Dental Companies
- Diagnostics Compa...
This report includes details on 25 emerging medical technology companies that have been identified by LSI\'s in-house research team in April 2013.
All companies include technology, market(s), key executive, and contact information.
Coverage includes innovations in a broad spectrum of medical technology areas including:
- Aesthetics/Dermatology Companies
- Biomaterials Companies
- Biotechnology/Cell Therapy Companies
- Cardiovascular Companies
- Dental Companies
- Diagnostics Companie...